SE9601396D0 - New therapeutic treatment 2 - Google Patents

New therapeutic treatment 2

Info

Publication number
SE9601396D0
SE9601396D0 SE9601396A SE9601396A SE9601396D0 SE 9601396 D0 SE9601396 D0 SE 9601396D0 SE 9601396 A SE9601396 A SE 9601396A SE 9601396 A SE9601396 A SE 9601396A SE 9601396 D0 SE9601396 D0 SE 9601396D0
Authority
SE
Sweden
Prior art keywords
therapeutic treatment
new therapeutic
inositols
osmolyte
taurine
Prior art date
Application number
SE9601396A
Other languages
English (en)
Inventor
Dieter Haeussinger
Original Assignee
Dieter Haeussinger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dieter Haeussinger filed Critical Dieter Haeussinger
Priority to SE9601396A priority Critical patent/SE9601396D0/sv
Publication of SE9601396D0 publication Critical patent/SE9601396D0/sv
Priority to AU23860/97A priority patent/AU2386097A/en
Priority to PCT/EP1997/001861 priority patent/WO1997038685A1/en
Priority to EP97919356A priority patent/EP0946167A1/en
Priority to CA002251071A priority patent/CA2251071A1/en
Priority to JP9536745A priority patent/JP2000508651A/ja
Priority to US08/878,557 priority patent/US5880098A/en
Priority to NO984759A priority patent/NO984759D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
SE9601396A 1996-04-12 1996-04-12 New therapeutic treatment 2 SE9601396D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9601396A SE9601396D0 (sv) 1996-04-12 1996-04-12 New therapeutic treatment 2
AU23860/97A AU2386097A (en) 1996-04-12 1997-04-14 Use of an osmolyte in the preparation of a medicament for treating complicati ons resulting from ischemia
PCT/EP1997/001861 WO1997038685A1 (en) 1996-04-12 1997-04-14 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
EP97919356A EP0946167A1 (en) 1996-04-12 1997-04-14 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
CA002251071A CA2251071A1 (en) 1996-04-12 1997-04-14 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
JP9536745A JP2000508651A (ja) 1996-04-12 1997-04-14 虚血を原因とする合併症を治療する医薬を製造するためのオスモライトの使用
US08/878,557 US5880098A (en) 1996-04-12 1997-06-19 Therapeutic treatment
NO984759A NO984759D0 (no) 1996-04-12 1998-10-12 Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601396A SE9601396D0 (sv) 1996-04-12 1996-04-12 New therapeutic treatment 2

Publications (1)

Publication Number Publication Date
SE9601396D0 true SE9601396D0 (sv) 1996-04-12

Family

ID=20402175

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601396A SE9601396D0 (sv) 1996-04-12 1996-04-12 New therapeutic treatment 2

Country Status (7)

Country Link
EP (1) EP0946167A1 (sv)
JP (1) JP2000508651A (sv)
AU (1) AU2386097A (sv)
CA (1) CA2251071A1 (sv)
NO (1) NO984759D0 (sv)
SE (1) SE9601396D0 (sv)
WO (1) WO1997038685A1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
BE1012495A3 (fr) * 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
ATE247981T1 (de) * 1999-06-12 2003-09-15 Bitop Ag Proteinenthaltende pharmazeutische zubereitung
EP1272201B1 (de) * 2000-04-12 2004-11-24 Bitop Aktiengesellschaft Für Biotechnische Optimierung Verwendung von kompatiblen soluten als substanzen mit radikalfangenden eigenschaften
JP5084089B2 (ja) * 2001-06-14 2012-11-28 大塚製薬株式会社 医薬組成物
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
DE10330768A1 (de) * 2003-07-07 2005-02-24 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eines Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung
WO2006050581A2 (en) * 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
MX2007013486A (es) 2005-04-27 2008-03-14 Jallal Messadek Combinaciones de insulinas.
DE102008006780A1 (de) * 2008-01-30 2009-08-06 Bitop Ag Verwendung von Tetrahydropyrimidinen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE464059C (sv) * 1988-09-15 1996-12-04 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
JP2642198B2 (ja) * 1989-08-24 1997-08-20 元庸 村上 胃粘膜障害治療剤
SE8904355D0 (sv) * 1989-12-21 1989-12-21 Perstorp Ab Medicament
WO1991014435A1 (en) * 1990-03-19 1991-10-03 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes
US5312839A (en) * 1991-03-05 1994-05-17 Regents Of The University Of California Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis
BE1007500A3 (fr) * 1992-09-18 1995-07-18 Pasteur Merieux Serums Vacc Solution de perfusion, de conservation et de reperfusion d'organes.
US5582839A (en) * 1995-04-18 1996-12-10 Nutrition 21 Magnesium taurate and other mineral taurates

Also Published As

Publication number Publication date
CA2251071A1 (en) 1997-10-23
NO984759L (no) 1998-10-12
WO1997038685A1 (en) 1997-10-23
JP2000508651A (ja) 2000-07-11
NO984759D0 (no) 1998-10-12
AU2386097A (en) 1997-11-07
EP0946167A1 (en) 1999-10-06

Similar Documents

Publication Publication Date Title
DK1039887T3 (da) Anvendelse af aminothiolforbindelser til behandling af neuro- og nefrolidelser og terapeutiske toksiciteter
HU912359D0 (en) The use of flupirtine active agents for treating muscle-tension
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
ES2174953T3 (es) Composiciones dermatologicas que contienen peroxido de benzoilo y un compuesto que reduce la irritacion de la piel.
NZ335981A (en) Ketobenzamides as calpain inhibitors
CA2304657A1 (en) Treatment of conduct disorder
SE9601396D0 (sv) New therapeutic treatment 2
PL310474A1 (en) Application of rilusole in treating neuro-aids diseases
EP1712236A3 (en) Tetracyclines for the treatment of acne
AP9200410A0 (en) Retroviral protease inhibitors.
IL110943A0 (en) Compositions for the treatment of skin disorders
DK71387A (da) Terapeutisk middel til behandling af psoriasis
IE820311L (en) Tetrahydronaphthalene and indane compounds
SE9601395D0 (sv) New therapeutic treatment 1
ES2139674T3 (es) Metodo para tratar la sintomatologia del sindrome premenstrual con vitamina d o vitamina d y calcio.
ATE273702T1 (de) Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
DE69924979D1 (de) Behandlung von chronischen schmerzen
ATE149840T1 (de) Behandlung von leberkrebs
PT100111A (pt) Composicao para o tratamento de um mamifero sofrendo de doenca proliferativa dapele, benigna ou maligna, compreendendo um analogo de somatostatina
EA199900174A1 (ru) Способ лечения биполярного расстройства
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
PT1133297E (pt) Nova aplicacao terapeutica da 1,6-dimetil-8beta-hidroximetil-10alfa-metoxiergolina